News

New results announced today by ViiV healthcare show that injection of long-acting pre-exposure prophylaxis (PrEP) cabotegravir every two months is 89% more effective than a daily Truvada oral pill (emtricitabine/tenofovir disoproxil fumarate) in a trial of women at increased risk of HIV acquisition.

Countering the COVID-19 infodemic requires not only facts, but also the coordinated and strategic advocacy for which those fighting HIV are renowned. Now more than ever, scientists need to counter lies and myths, and defend the integrity and independence of their enterprise. The emergence of the SARS-CoV-2 virus has not only led to the global COVID-19 pandemic, but also fueled an accompanying onslaught of misinformation. Some have promoted drugs such as hydroxychloroquine as cures for the disea...

Cori Vail has been elected as the ILF industry representative. Cori currently leads HIV Access Strategy & Impact efforts as part of Johnson & Johnson’s Global Public Health team. In this role, she is responsible for developing and executing insight-based strategies to accelerate adoption of transformational HIV innovation for underserved populations in resource-limited settings. Cori joined the Johnson & Johnson family of companies in 2003 and held numerous roles across engineering,...

It is with sadness and much gratitude that, on behalf of IAS - the International AIDS Society - Governing Council, I am letting you know that IAS Executive Director Kevin Osborne has announced his departure from the organization. After close to five successful years at the IAS, first as Director of HIV Programmes and Advocacy, and then as Executive Director, Kevin will depart at the end of September 2020 to join his partner abroad. With Kevin at the helm, the organization has benefited from his...

IAS has announced nine newly elected and three re-elected members to its Governing Council. Adeeba Kamarulzaman of Malaysia is the new IAS President and Sharon Lewin of Australia the President-Elect, with Jennifer Kates of the United States serving as Treasurer. “The new members joining the IAS Governing Council add a great diversity of skills and experiences,” IAS President Adeeba Kamarulzaman said. “They will be pivotal in steering IAS into the future and dealing with a fast-changing scien...

As champions of health and rights, we add our voices to the global chorus condemning the murders of George Floyd, Ahmaud Arbery, Breonna Taylor and countless others – and denounce the structural racism that enabled their deaths.

The International AIDS Society (IAS) mourns the passing of Professor Gita Ramjee, world-renowned HIV scientist and Chief Scientific Officer at the Aurum Institute, who died in South Africa on Tuesday, 31 March from COVID-19 related complications.

“It`s hard to know if this is a cure, only time will tell, but this is looking very promising,” said Sharon Lewin, IAS Governing Council member and Director of the Peter Doherty Institute for Infection and Immunity at the University of Melbourne in Australia. Lewin is also Co-Chair with Mark Dybul of the IAS initiative Towards an HIV Cure.

Undetectable Equals Untransmittable (U=U) is an established and scientifically sound and proven concept in HIV prevention. A staggering body of evidence has shown that people living with HIV who achieve and maintain an undetectable viral load by taking and adhering to antiretroviral therapy as prescribed cannot sexually transmit the virus to others.

3 February 2020 (Geneva, Switzerland) - The Global HIV Vaccine Enterprise (the Enterprise), hosted by the International AIDS Society (IAS), shares the deep disappointment that the Phase 2b/3 HIV vaccine study HVTN 702 has been stopped by the trial sponsor, the National Institute of Allergy and Infectious Diseases (NIAID).